Venadaparib Is a Novel and Selective PARP Inhibitor with Improved Physicochemical Properties, Efficacy, and Safety.
Lee M, Je IG, Kim JE, Yoo Y, Lim JH, Jang E, Lee Y, Song DK, Moon AN, Kim JA, Jeong J, Park JT, Lee JW, Yang JH, Hong CH, Park SY, Park YW, Baek NS, Lee S, Ha KS, Choi S, Lee WS.
Lee M, et al. Among authors: yang jh.
Mol Cancer Ther. 2023 Mar 2;22(3):333-342. doi: 10.1158/1535-7163.MCT-22-0068.
Mol Cancer Ther. 2023.
PMID: 36808277
Free PMC article.